🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Min Lu

Shanghai Electric (China)

ORCID: 0000-0002-8106-0587

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 4 papers. Top paper: “Vorasidenib, a Dual Inhibitor of Mutant IDH1/2, in Recurrent or Progressive Glioma; Results of a First-in-Human Phase I Trial”.

Vorasidenib, a Dual Inhibitor of Mutant IDH1/2, in Recurrent or Progressive Glioma; Results of a First-in-Human Phase I Trial

Clinical Cancer Research(2021)10.1158/1078-0432.ccr-21-0611

N/A

4.8DataRank · unranked

264 citations

Marta Peñas-Prado, Katherine B. Peters, Howard A. Burris, Elizabeth A. Maher, Filip Jankú +16 more

Small-molecule targeted therapies induce dependence on DNA double-strand break repair in residual tumor cells

Science Translational Medicine(2022)10.1126/scitranslmed.abc7480

N/A

0DataRank · unranked

45 citations

Min Lu, Hazel X. Ang, Ryan S. Soderquist, Christine E. Eyler, Haley M. Hutchinson +12 more

P2RY2-AKT activation is a therapeutically actionable consequence of XPO1 inhibition in acute myeloid leukemia

Nature Cancer(2022)10.1038/s43018-022-00394-x

N/A

0DataRank · unranked

42 citations

Justine C. Rutter, Abigail Xie, Shane T. Killarney, Camille Vaganay, Chaı̈ma Benaksas +28 more

Inhibition of D-2HG leads to upregulation of a proinflammatory gene signature in a novel HLA-A2/HLA-DR1 transgenic mouse model of IDH1R132H-expressing glioma

Journal for ImmunoTherapy of Cancer(2022)10.1136/jitc-2022-004644

N/A

0DataRank · unranked

34 citations

Akane Yamamichi, Tiffany Chen, Rohini Narayanaswamy, Sébastien Ronseaux, Christine C. Hudson +11 more